Rebamipide Report for Patients Like You

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Rebamipide Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Rebamipide?

Rebamipide, an international product, is a cytoprotective agent which is used in the treatment of peptic ulcer disease and gastritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Mouth sores (ulcers)	1	0
Genital ulcers (sores)	1	0
Behcet's Syndrome	1	0

See all 2 patients currently taking Rebamipide

Mouse over the table for more information

Reported Dosages

	100 mg daily	300 mg daily
	1	1

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Rebamipide

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	1	0	0

Report created on May 28, 2012.